Summary Safety Review - Propecia (finasteride 1 mg) and Proscar (finasteride 5 mg) - Assessing the Potential Risk of Seizures

Description

Health Canada carried out a safety review to look at the potential risk of seizures in patients taking finasteride after cases of seizures were published in the WHO Pharmaceuticals NewsletterFootnotea.

Resources

Name Format Description Link
Summary Safety Review - Propecia (finasteride 1 mg) and Proscar (finasteride 5 mg) - Assessing the Potential Risk of Seizures HTML https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/safety-reviews/summary-safety-review-propecia-finasteride-proscar-finasteride-assessing-potential-risk-seizures.html
Summary Safety Review - Propecia (finasteride 1 mg) and Proscar (finasteride 5 mg) - Assessing the Potential Risk of Seizures HTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/examens-innocuite/resume-examen-innocuite-propecia-finasteride-proscar-finasteride-evaluation-risque.html

Tags

Topics

Categories